Celldex Therapeutics, Inc.

CLDX Nasdaq SEC CIK 744218
Follow Celldex Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $0
Net income −$75.6M −12.7% vs same quarter last year
EPS, diluted −$0.96 +5% vs same quarter last year
Operating cash flow −$65M −33.7% vs same quarter last year
Revenue by quarter
$1.2M
$695K
$730K
$0
$121K
$15K
$22K
$0
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$300M−$200M−$100M$0$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$1.5M−$258.8M
FY24$7M−$157.9M
FY23$6.9M−$141.4M
FY22$2.4M−$112.3M
FY21$4.7M−$70.5M
FY20$7.4M−$59.8M
FY19$3.6M−$50.9M
FY18$9.5M−$151.2M
FY17$12.7M−$93M
FY16$6.8M−$128.5M
FY15$5.5M−$127.2M
FY14$3.6M−$118.1M
FY13$4.1M−$81.6M
FY12$11.2M−$59.1M
FY11$9.3M−$44.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20000%−15000%−10000%−5000%0%5000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2587.1%−18599.8%−16748%
FY2497.2%−2778.9%−2248.8%
FY2395.6%−2245.3%−2054.8%
FY2295.8%−4889%−4765.6%
FY2197.8%−1531.8%−1516%
FY2097.3%−854.1%−805.9%
FY1997.2%−1540.2%−1424%
FY1892.7%−1640.1%−1585.1%
FY1794.5%−953.7%−730.1%
FY1676.4%−1958.7%−1894%
FY15-−2363.9%−2321.1%
FY14-−3414.1%−3292.8%
FY13-−1981.1%−1983.7%
FY12-−518.5%−527.8%
FY11-−468.4%−483.5%
Free cash flowOperating cash flow minus capital expenditure
−$300M−$200M−$100M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$213.7M
FY24−$159.7M
FY23−$109.1M
FY22−$105.6M
FY21−$62.2M
FY20−$42M
FY19−$47.1M
FY18−$76M
FY17−$101.7M
FY16−$115.8M
FY15−$103.8M
FY14−$103.5M
FY13−$71.9M
FY12−$50.1M
FY11−$36.2M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Celldex Therapeutics
  • Healthcare median
−20000%−15000%−10000%−5000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearCelldex TherapeuticsHealthcare median
FY25−16748%−30.6%
FY24−2248.8%−47%
FY23−2054.8%−58%
FY22−4765.6%−80.4%
FY21−1516%−71.9%
FY20−805.9%−62.2%
FY19−1424%−46.3%
FY18−1585.1%−49.6%
FY17−730.1%−45.9%
FY16−1894%−36%
FY15−2321.1%−38.4%
FY14−3292.8%−35.5%
FY13−1983.7%−37.1%
FY12−527.8%−29.1%
FY11−483.5%−27.9%